A nurse is caring for a client who has diabetes insipidus and is receiving desmopressin by intermittent IV bolus. Which of the following manifestations should the nurse identify as an indication of a therapeutic response to the medication?
Increase in serum sodium
Decrease in urine output
Increase in heart rate
Decrease in blood pressure
The Correct Answer is B
A. Increase in serum sodium: Desmopressin, a synthetic form of vasopressin, works to decrease urine output and increase water reabsorption in the kidneys. Therefore, a therapeutic response to desmopressin would not result in an increase in serum sodium; rather, it would aim to normalize serum sodium levels by reducing excessive urine output.
B. Decrease in urine output: The primary therapeutic goal of desmopressin in the treatment of diabetes insipidus is to decrease urine output by increasing water reabsorption in the kidneys. Therefore, a decrease in urine output would indicate a positive response to the medication.
C. Increase in heart rate: Desmopressin primarily affects kidney function by increasing water reabsorption and does not typically have a direct effect on heart rate. Therefore, an increase in heart rate would not be a manifestation of a therapeutic response to desmopressin.
D. Decrease in blood pressure: Desmopressin works to increase water reabsorption in the kidneys and does not typically cause significant changes in blood pressure. Therefore, a decrease in blood pressure would not be a manifestation of a therapeutic response to desmopressin.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is D
Explanation
A. Treatment for active pulmonary tuberculosis typically lasts 6 to 9 months, not 3 years.
B. Monitoring kidney function is not typically required for tuberculosis medication; however, liver function tests may be needed.
C. Tuberculin skin tests are used for diagnosis, not for monitoring treatment progress.
D. Treatment of active pulmonary tuberculosis usually involves a combination of antibiotics, typically two or more medications, to prevent the development of drug-resistant strains.
Correct Answer is C
Explanation
A. Epoetin alfa is not administered intranasally.
B. Epoetin alfa is not administered orally because it would be destroyed by digestive enzymes and have poor absorption.
C. Epoetin alfa is typically administered subcutaneously, as it is a recombinant human erythropoietin that stimulates red blood cell production.
D. Epoetin alfa is not administered trans dermally.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.
